BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Janssen Pharmaceutical Inc.  

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: 609-730-2000 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
FDA OKs Janssen Pharmaceutical Inc. 's Topamax For Migraine Prevention In Adolescents 3/28/2014 2:48:04 PM    More...
Janssen Pharmaceutical Inc. To Present New Simeprevir Data At The International Liver Congress™ 2014 Of The European Association For The Study Of The Liver (EASL) 3/25/2014 6:46:33 AM    More...
Addex Therapeutics (ADXN.SW)-Janssen Pharmaceutical Inc. Team's Depression Drug Fails In Phase 2a Trial 2/10/2014 7:32:27 AM    More...
Janssen Pharmaceutical Inc. 's ZYTIGA® Now Reimbursed in Quebec For Use Prior To Chemotherapy In Men With Metastatic Prostate Cancer 2/6/2014 10:03:05 AM    More...
Portola Pharmaceuticals, Inc. Enters Into Clinical Collaboration Agreement With Bayer HealthCare (BAY) And Janssen Pharmaceutical Inc. For Phase 3 Studies Of Andexanet Alfa*, Investigational Factor Xa Inhibitor Reversal Agent, And XARELTO® 2/3/2014 6:49:11 AM    More...
Johnson & Johnson (JNJ)'s Janssen Pharmaceutical Inc. Loses $11 Million Jury Verdict Over Topamax 11/19/2013 8:18:26 AM    More...
Janssen Pharmaceutical Inc. 's Topamax Users Blame Drug for Birth Defects 10/16/2013 7:06:35 AM    More...
Hutchison Medipharma Receives $6 Million Milestone From Janssen Pharmaceutical Inc. 10/10/2013 11:13:05 AM    More...
Janssen Pharmaceutical Inc. Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C From GlaxoSmithKline (GSK) 10/8/2013 9:36:28 AM    More...
CureVac GmbH to Collaborate With Janssen Pharmaceutical Inc. of mRNA-Based Influenza Vaccine 10/3/2013 9:03:59 AM    More...

//-->